1,031 results on '"Massie, Barry M."'
Search Results
102. Negative, neutral, and discordant results: What should an editor do?
103. Beware the rising creatinine level
104. Are We Inhibited?: Renal Insufficiency Should Not Preclude the Use of ACE Inhibitors for Patients With Myocardial Infarction and Depressed Left Ventricular Function
105. Evaluating Hypertension Control in a Managed Care Setting
106. A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: The U.S. Ecadotril Pilot Safety Study
107. Outcome Following Acute Myocardial Infarction: Are Differences Among Physician Specialties the Result of Quality of Care or Case Mix?
108. A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States
109. 15 years of heart-failure trials: what have we learned?
110. What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians
111. The prognostic importance of different definitions of worsening renal function in congestive heart failure
112. Treating heart failure: It's time for new paradigms and novel approaches
113. Journal of Cardiac Failure: The next phase
114. Response to a Second Single Antihypertensive Agent Used as Monotherapy for Hypertension After Failure of the Initial Drug
115. Management of Heart Failure: III. The Role of Revascularization in the Treatment of Patients with Moderate or Severe Left Ventricular Systolic Dysfunction
116. Management of Heart Failure: II. Counseling, Education, and Lifestyle Modifications.
117. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals
118. Publication Of Sponsored Symposiums In Medical Journals
119. First-line therapy for hypertension: different patients, different needs
120. Angiotensin-converting enzyme inhibitors as cardioprotective agents
121. To combat hypertension, increase activity
122. Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE)
123. All patients with left ventricular systolic dysfunction should be treated with an angiotensin-converting enzyme inhibitor: a protagonist's viewpoint
124. Beta-adrenergic blocker mortality trials in congestive heart failure
125. Heart Failure in the Elderly
126. Heart Failure in the Elderly
127. Myocardial Hypertrophy and Cardiac Failure: A Complex Interrelationship
128. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study
129. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality
130. Interaction between aspirin and angiotensin-converting enzyme inhibitors: real or imagined
131. Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial
132. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies
133. 58 - Insuficiência cardíaca: fisiopatologia e diagnóstico
134. Silent Cerebral Infarction in Heart Failure: Vascular or Thromboembolic?
135. Improving care for patients with acute heart failure: Before, during and after hospitalization
136. Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical Trials 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco
137. Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial
138. Are We Inhibited?
139. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure
140. Rolofylline, an Adenosine A(sub 1)-Receptor Antagonist, in Acute Heart Failure
141. Abstract 224: No Difference in Complications or Mortality by Implanted Cardioverter Defibrillator Type in Veterans Enrolled in The Outcomes Among Veterans with Implantable Devices (OVID) Registry
142. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities
143. Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes Lessons Learned and Directions Forward
144. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial
145. What is the significance of a journal's impact factor?
146. LVADs as long-term cardiac replacement: Success but on what terms and at what cost?
147. Remodeling the Journal of Cardiac Failure: How can the readership contribute?
148. A personal comment on the 2001 Heart Failure Society of America annual scientific meeting: Defining the character of our organization
149. High-Sensitivity C-Reactive Protein in Acute Heart Failure: Insights From the ASCEND-HF Trial
150. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.